GlaxoSmithKline Gives Update on Agreement with World Health Organization to Support Deworming of School Age Children in Endemic Countries

September 22, 2011

GlaxoSmithKline (GSK) today announced progress on its commitment to expand the donation of albendazole to the World Health Organization (WHO) to treat school age children at risk of intestinal worms, known as soil-transmitted helminths (STH). An agreement signed today formalises the pledge made by GSK in October 2010 to provide an additional 400 million tablets of albendazole per year to WHO to enable de-worming of school age children in Africa. Today’s agreement also provides for albendazole donations to be made to STH endemic countries around the world beyond Africa to ensure the greatest possible benefit is derived from this donation.

USAID from the American People   RTI International